Cost-effectiveness of the use of low- and high-potency statins in people at low cardiovascular risk (Q35551084)

8 August 2017

Cost-effectiveness of the use of low- and high-potency statins in people at low cardiovascular risk (English)

1 reference

8 August 2017

Marcello Tonelli

3

1 reference

8 August 2017

Don Husereau

8

1 reference

8 August 2017

Natasha Wiebe

9

1 reference

Alberta Kidney Disease Network

8 August 2017

12

object named as

Alberta Kidney Disease Network

1 reference

8 August 2017

Jon Conly

1

1 reference

8 August 2017

Fiona Clement

2

1 reference

8 August 2017

Brenda Hemmelgarn

4

1 reference

8 August 2017

Scott Klarenbach

5

1 reference

8 August 2017

Anita Lloyd

6

1 reference

8 August 2017

Finlay A McAlister

7

1 reference

8 August 2017

Flora Au

10

1 reference

8 August 2017

Braden Manns

11

1 reference

8 August 2017

language of work or name

English

0 references

publication date

11 October 2011

1 reference

Canadian Medical Association Journal

8 August 2017

1 reference

8 August 2017

183

1 reference

8 August 2017

E1180-8

1 reference

8 August 2017

16

1 reference

Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis

8 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3216439

By Jove! What is a clinician to make of JUPITER?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3216439

Cholesterol lowering, cardiovascular diseases, and the rosuvastatin-JUPITER controversy: a critical reappraisal

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3216439

Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3216439

2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3216439

Is measuring C-reactive protein useful for guiding treatment in women > or = 60 years and men > or = 50 years of age?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3216439

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3216439

A population-based analysis of statin utilization in British Columbia

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3216439

A systematic review and economic evaluation of statins for the prevention of coronary events.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3216439

Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20,536 people

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3216439

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3216439

The 4S study. Implications for prescribing

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3216439

How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3216439

Cholesterol-lowering therapy for primary prevention: still much we don't know

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3216439

Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3216439

Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3216439

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3216439

Two cases of rhabdomyolysis associated with high-dose simvastatin.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3216439

Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TEXCAPS): additional perspectives on tolerability of long-term treatment with lovastatin

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3216439

Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3216439

Alternative strategies for stroke care: a prospective randomised controlled trial

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21989469

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Overview of 'APPROACH' - the Alberta Provincial Program for Outcome Assessment in Coronary Heart Disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21989469

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21989469

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1503/CMAJ.101281

1 reference

8 August 2017

1 reference

8 August 2017

1 reference